Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $402.03 USD
Change Today -2.60 / -0.64%
Volume 600.4K
As of 12:16 PM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Douglas Edward Williams Ph.D.

Executive Vice President of Research & Development, Biogen Inc.
AgeTotal Calculated CompensationThis person is connected to 71 board members in 6 different organizations across 15 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Douglas Edward Williams, also known as Doug, Ph.D. has been an Executive Vice President of Research & Development at Biogen Inc. since January 5, 2011. Dr. Williams served as Secretary of Fred Hutchinson Cancer Research Center. Dr. Williams served as the Chief Executive Officer of Zymogenetics Inc. from January 2, 2009 to November 2010. Dr. Williams served as the President of Zymogenetics Inc. from July 2, 2007 to January 2009. Dr. Williams joined ZymoGenetics Inc. ...

Read Full Background

Corporate Headquarters*

225 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 617-679-2000
Fax: --

Board Members Memberships*

Former Chairman of The Board
Former Trustee
Former Director and Director of Strategic Development and Health
Former Chief Technology Officer, Executive Vice President and Director
Former Director
Former Director and Member of Compensation Committee
Former Independent Director, Chairman of Compensation Committee and Member of Corporate Governance & Nominating Committee
Former Director and Member of Audit Committee
Former Chief Executive Officer
Director and Member of Governance & Nominating Committee


State University of New York at Buffalo Roswell Park Memorial Institute Division
University of Massachusetts Lowell

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIIB:US $402.32 USD -2.31


Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at